Atıf Formatları
Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Y. Baran Et Al. , "Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6, pp.673-679, 2011

Baran, Y. Et Al. 2011. Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6 , 673-679.

Baran, Y., Zencir, S., Cakir, Z., ÖZTÜRK, E., & TOPÇU, Z., (2011). Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6, 673-679.

Baran, YUSUF Et Al. "Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition," JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6, 673-679, 2011

Baran, YUSUF Et Al. "Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6, pp.673-679, 2011

Baran, Y. Et Al. (2011) . "Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition." JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , vol.36, no.6, pp.673-679.

@article{article, author={YUSUF BARAN Et Al. }, title={Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition}, journal={JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS}, year=2011, pages={673-679} }